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Abstract: Metabolomics has emerged as a promising technique to understand relationships between
environmental factors and health status. Through comprehensive profiling of small molecules in
biological samples, metabolomics generates high-dimensional data objectively, reflecting exposures,
endogenous responses, and health effects, thereby providing further insights into exposure-disease
associations. However, the multivariate nature of metabolomics data contributes to high complexity
in analysis and interpretation. Efficient visualization techniques of multivariate data that allow
direct interpretation of combined exposures, metabolome, and disease risk, are currently lacking.
We have therefore developed the ‘triplot’ tool, a novel algorithm that simultaneously integrates and
displays metabolites through latent variable modeling (e.g., principal component analysis, partial
least squares regression, or factor analysis), their correlations with exposures, and their associations
with disease risk estimates or intermediate risk factors. This paper illustrates the framework of
the ‘triplot’ using two synthetic datasets that explore associations between dietary intake, plasma
metabolome, and incident type 2 diabetes or BMI, an intermediate risk factor for lifestyle-related
diseases. Our results demonstrate advantages of triplot over conventional visualization methods in
facilitating interpretation in multivariate risk modeling with high-dimensional data. Algorithms,
synthetic data, and tutorials are open source and available in the R package ‘triplot’.
Keywords: triplot; metabolomics; multivariate risk modeling; environmental factors; disease risk
1. Introduction
Environmental factors, such as diet, smoking, and pollutants, are associated with risk of developing
non-communicable diseases (NCDs), including obesity, type 2 diabetes (T2D), and cardiovascular
disease [1], which together constitute the leading cause of morbidity, mortality, and high healthcare
costs worldwide. The role of lifestyle factors in development and progression of NCDs has often been
studied in prospective cohorts or case-controlled studies, where associations of specific exposures with
health outcomes or intermediate risk markers of NCDs (e.g., blood pressure, lipid profiles, and body
weight) are assessed. Several challenges exist in the research on exposure–health relationships,
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including the measurement of environmental factors and the lack of understanding of underlying
molecular mechanisms that are affected by the exposures [2].
Metabolomics is the comprehensive assessment of metabolites in biological samples, which
enables investigation of physiological and biological states at the molecular phenotype level, reflecting
both exogenous and endogenous exposures. Thus, metabolomics could potentially advance the
understanding of associations between exposures and health status [3–5]. For example, using
metabolomics to identify metabolite biomarkers objectively reflecting dietary exposures could provide
a complement to self-reported dietary assessments that are known to suffer from large systematic and
random measurement errors [6]. Metabolomics can also be used to link exposures to outcomes [7,8] by
detecting endogenous changes in response to exposures [3]. However, in addition to these advantages,
application of metabolomics in epidemiologic research makes interpretation and visualization of the
results more complex due to the high dimensionality of the data.
Both multivariate analysis (e.g., reduced rank/component-based techniques) and univariate
analysis are routinely used in metabolomics studies to extract meaningful information from complex
datasets and thus provide biological knowledge of the research question under investigation [9].
Univariate analyses allow both for simultaneous investigation of multiple study factors, time series
data, as well as adjustment for potential covariates or confounders. In general, univariate methods
also provide more straightforward interpretation of results compared to multivariate analyses, which
on the other hand make use of all variables simultaneously and are well-equipped to deal with high
collinearity, which is often a challenge in epidemiological studies [10]. However, they offer limited
options to investigate several study factors simultaneously, i.e., analyze data from time series or adjust
for potential covariates or confounders.
Results from metabolomics studies aiming to investigate exposure–disease relationships are often
using a combination of figures to illustrate the findings. Observation scores and metabolite loadings
from latent variable (LV) modeling (e.g., principal component analysis (PCA), factor analysis (FA),
or partial least squares (PLS)) can be shown, e.g., in a biplot (Figure 1a), to identify outliers, to visualize
separation of individuals into subgroups, and to examine how individual metabolites contribute to
the LVs. Correlations between individual metabolites or LV scores and exposures are then frequently
visualized using heatmaps (Figure 1b). Finally, individual metabolites or LV scores can be used as
independent variables to model disease outcome or intermediate risk markers. Associated risk can
then be visualized as odds ratios (ORs) or beta coefficients from logistic or linear regressions in a forest
plot (Figure 1c). However, the lack of effective tools for direct interpretation of the relationship between
exposures, metabolome, and outcome measure by visualization of combined data makes interpretation
and communication of findings difficult.
We therefore developed the novel ‘triplot’ tool to facilitate visualization and interpretation of
multivariate risk modeling, which enables a global, combined overview of information representing the
metabolome (or other types of multivariate data), exposures, or environmental factors of interest and
associated health outcomes (i.e., disease outcomes or intermediate risk factors) (Figure 1d). We present
the workflow of the triplot package and demonstrate its applicability using two synthetic datasets
that were simulated from a case-controlled study nested within the Swedish prospective Västerbotten
Intervention Programme cohort [11] and from a cross-sectional study of Carbohydrate Alternatives
and Metabolic Phenotypes in Chinese young adults [12].
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Figure 1. Using metabolomics data to investigate the relationship between exposures and disease 
risk. In a standard approach, latent variable (LV) modeling (a) is used to achieve a reduced rank 
approximation of the metabolomics data. Correlation heatmaps (b) and forest plots (c) are then used 
to associate observation scores with exposures and risks, respectively. For more direct interpretation, 
LV modeling, and their associations with exposures and risks can be visualized jointly in a triplot (d). 
HFI: Healthy Food Index; BSDS: Baltic Sea Diet Score; PC: Principal Component; OR: Odds Ratio; CI: 
Confidence Interval. lysoPC: Lysophosphatidylcholine; lysoPE: Lysophosphoethanolamine; EPA: 
Eicosapentaenoic acid; DHA: Docosahexaenoic acid; RP: reverse phase chromatography positive 
mode ionization; RN: reverse phase chromatography negative mode ionization. 
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‘HealthyNordicDiet’: This synthetic dataset was simulated from data used in a case-controlled 
study nested within the Swedish prospective Västerbotten Intervention Programme (VIP) cohort [8]. 
The entire study protocol was approved by the Regional Ethics Committee in Uppsala, Sweden 
(registration number 2014/011). The original study material was used to investigate how the plasma 
metabolome and the risk of developing T2D were related to compliance to a Healthy Nordic Diet [8]. 
Detailed information on study design and metabolomics data acquisition is provided elsewhere 
[7,8]. In brief, the original dataset included 421 participants from VIP at baseline (median time of 7 
years before T2D diagnosis). Each case was individually matched to one nondiabetic participant on 
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2. Materials and Methods
2.1. Synthetic Data
‘HealthyNordicDiet’: This synthetic dataset was simulated from data used in a case-controlled study
nested within the Swedish prospective Västerbotten Intervention Programme (VIP) cohort [8]. The
entire study protocol was approved by the Regional Ethics Committee in Uppsala, Sweden (registration
number 2014/011). The original study material was used to investigate how the plasma metabolome
and the risk of developing T2D were related to compliance to a Healthy Nordic Diet [8]. Detailed
information on study design and metabolomics data acquisition is provided elsewhere [7,8]. In brief,
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the original dataset included 421 participants from VIP at baseline (median time of 7 years before T2D
diagnosis). Each case was individually matched to one nondiabetic participant on age, gender, sampling
date, and sample storage time. Untargeted liquid chromatography quadrupole time-of-flight mass
spectrometry (LC-qTOF-MS) metabolomics was performed on plasma samples using reverse phase and
hydrophilic interaction chromatography in both positive and negative electrospray ionization modes.
In total, 31 plasma metabolites related to a priori-defined healthy Nordic dietary indices, i.e., the Baltic
Sea Diet Score (BSDS) and Healthy Nordic Food Index (HNFI), were selected using a random forest
algorithm incorporated into a repeated double cross-validation framework with unbiased variable
selection [8,13]. Subsequently, associations were investigated between the 31 dietary index-related
metabolites, dietary intakes, and T2D risk [8].
The simulated data contains three data frames: Baseline characteristics of participants (BaselineData,
11 variables), identified metabolites associated with healthy Nordic diet (MetaboliteData, 31 variables),
and food items associated with Healthy Nordic Diet (FoodData, 17 variables). The data frames are
row-wise matched by observation and consist of 1000 synthetic observations that correspond to
500 case-controlled pairs matched by gender and age.
CAMP: This synthetic dataset was simulated from real data used in a cross-sectional study of
carbohydrate alternatives and metabolic phenotypes [12]. The study was approved by the ethical
committee of Xi’an Jiaotong University Health Science Center, and all participants provided written
informed consent. The original data were obtained from fasting plasma samples from 86 men and
women that were between 18–35 years of age. Samples were analyzed by untargeted LC-qTOF-MS
metabolomics using reverse phase chromatography in both positive and negative electrospray ionization
modes. Associations were investigated between an optimal selection of plasma metabolites predictive
of BMI and dietary intakes as well as several clinical measurements.
The simulated data contains three data frames: Clinical measurements (ClinData, 11 variables),
plasma metabolites predictive of BMI (MetaboliteData, 20 variables), and dietary intake as measured by
food frequency questionnaires (FoodData, 11 variables). The data frames are row-wise matched by
observation and consist of 300 synthetic observations.
2.2. Algorithm Description
The ‘triplot’ is a novel tool that simultaneously integrates three levels of information, effectively
providing interpretable visualization of multivariate associations between exposures, metabolome,
and disease risk by superimposing LVs from multivariate modeling of, e.g., metabolomics data with
correlations of exposures (or other correlations) and associations with disease risk or intermediate risk
markers (Figure 2). An overview of the functions and workflow of the triplot package is presented in
Table 1.
In the first layer of the triplot, LV modeling is performed on a high-dimensional dataset, generated
from, e.g., metabolomics, proteomics or other omics, to reduce the data dimensionality, and to aggregate
correlated variables into LVs. The choice of LV modeling method depends on the preference of the
user, the data, and the analytical question. The triplot algorithm accepts input from any LV modeling
that conforms to reporting observation scores and variable loadings. Frequently used LV algorithms
include unsupervised PCA and FA as well as supervised PLS analyses. PCA and FA are used to
describe the total variability among the observed (metabolomics) variables using a lower number of
LVs called principal components or factors, respectively. PLS is conceptually similar but identifies
components that are instead optimized for covariation between the observed (independent) variables
and an outcome (dependent) variable [14,15].
There are several methods to determine the number of LVs to retain in unsupervised LV modeling,
i.e., PCA and FA [16]. Among them, a scree plot, which shows how much variation each factor or
principal component captures from the data, and very simple structure analysis are commonly used [17].
For supervised modeling like PLS, the number of LVs should be optimized by cross validation. Out
of several cross-validation approaches, repeated double cross validation has shown advantages in
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estimation of the optimum number of PLS components and estimations of prediction errors over
several other commonly used validation approaches, such as k-fold and leave-n-out [13,18,19].Metabolites 2019, 9, x 5 of 12 
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Associated correlations and risk estimates are added to the LV modeling in a modular, easy-to-use
workflow, and a summarized overview in the form of a heatmap can then be generated to assist in
selecting LVs to investigate using the triplot function.
Table 1. Overview of the workflow and main functions in the ‘triplot’ R package.
Function Description
First layer: Latent variable (LV) modeling
Custom a Perform LV modeling of high-dimensional (metabolomics) data.
makeTPO() a Initiate a triplot object (TPO) from LV model
Second layer: Correlations
makeCorr()
or custom b
Perform correlation analysis between LV observation scores and
exposures or covariates.
addCorr() Add correlation results to the TPO.
Third layer: Associated risk
crudeCLR(),
crudeLR(),
or custom c
Calculate risk associations (i.e., odds ratio or hazard ratio) in
(conditional) logistic regression or association with intermediate risk
markers (i.e., beta coefficient) in linear regression.
addRisk() Add risk associations to the TPO.
Visualizations
checkTPO() Generate a heatmap visualizing correlations and risk associations toidentify relevant LVs for the triplot visualization.
triplot() Create a triplot containing LV analysis results, correlations, and riskassociations.
a Actual LV modeling is purposely omitted from the triplot package to give the user the choice of LV method,
such as PCA, FA, or PLS. The makeTPO() function will accept any input that conforms to scores and loadings. b
makeCorr() constitutes a convenience function for standard correlation analysis (Pearson, Spearman, Kendall). Partial
correlation requires custom scripts and is covered in the tutorial. c crudeLR() and crudeCLR() constitute convenience
functions for (conditional) logistic regression. Adjusting associations for covariates requires custom scripts and is
covered in the tutorial.
2.3. Software and Implementation
The triplot algorithm is publicly available in an open source R implementation
(https://gitlab.com/CarlBrunius/triplot). The repository provides the ‘triplot’ R package, installation
instructions, synthetic data, and a tutorial that covers the case studies described in this manuscript in a
high level of detail, as well as several additional case studies.
3. Results and Discussion
We applied various analyses on the two simulated datasets available from the package to
demonstrate the wide applicability of the triplot. Disease risk (discrete outcome) is modeled using the
‘HealthyNordicDiet’ dataset and intermediate risk markers (continuous outcomes) are modeled using
the ‘CAMP’ dataset.
3.1. HealthyNordicDiet
The original study was set up to explore plasma metabolites that could objectively reflect healthy
Nordic dietary patterns in a matched case-controlled study and to assess associations between
such patterns and later development of T2D [8]. The processing pipeline for the generation and
visualization of the original data is described in Supplementary Materials Figure S1. A global overview
of intercorrelations between plasma metabolites related to the healthy Nordic diet, dietary intake
variables, as well as T2D risk is shown in Figure 3 (Tutorial—Example 1). PC1 constituted a metabolite
profile, which directly reflected the healthy Nordic dietary indices and individual food components of
the indices and was not associated with T2D risk after adjustment for lifestyle-related factors. PC2
instead, while it was negatively correlated with the healthy Nordic dietary indices, it was predominantly
correlated with foods not part of the indices, e.g., margarine, sausages, and poultry, and also more
strongly associated with risk of developing T2D, even after adjustment for BMI and lifestyle-related
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factors (smoking status, education, physical activity, and total energy intake). Results from different
risk modeling approaches can easily be incorporated into the triplot framework, e.g., using normal
logistic regression, which achieved similar OR estimates as conditional logistic regression (Figure 3,
Tutorial—Example 2).
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Figure 3. A PCA-based triplot visualizing the inter-correlation between plasma metabolites related to
healthy Nordic diet and dietary intake variables as well as association with type 2 diabetes (T2D) risk.
Odds ratios of T2D were calculated using conditional logistic regression with or without adjusting for
BMI and lifestyle-related confounders (smoking status, education, physical activity, and total energy
intake) (OR_A and OR, respectively). Risk associations were calculated similarly using unconditional
logistic regression (OR_AU and OR_U, respectively). Correlations between PCA components and
dietary intakes were calculated using partial Pearson method, adjusted for case-controlled status,
gender, age, BMI, and lifestyle-related confounders (smoking status, education, and physical activity).
Only metabolite feature loadings > 0.25 and dietary intake variables significantly correlated with the
PCA components are shown.
Importantly, all information incorporated in the triplot visualization could have been obtained
using conventional tools, such as separate PCA biplots, heatmaps, and forest plots for risk estimates
(Figure 1). However, such an approach presents results scattered across different tables and/or figures,
which impedes the direct interpretation of the results. The triplot algorithm instead provides an
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integrated overview of metabolites as well as associated exposures and risk estimates, which intuitively
and clearly presents relevant biological information: The results obtained from synthetic data, i.e., that
the metabolite profile related to healthy Nordic diet is not associated with T2D whereas that of more
unhealthy dietary choices is, effectively mirror those that were obtained from authentic data [8].
3.2. CAMP
Obesity has been associated with increased morbidity and mortality from NCDs, and high BMI
has also been associated with the intake of unhealthy food, i.e., fast food and red/processed meat [22,23].
The cross-sectional study of Carbohydrate Alternatives and Metabolic Phenotypes in Chinese young
adults was therefore designed to assess relationships between diet, metabolic profiles, and risk
factors of metabolic diseases, using both traditional epidemiological approaches and metabolomics
techniques [12].
Intercorrelations between BMI-related plasma metabolites, dietary intakes, and metabolic traits
are shown in Figure 4 (Tutorial—Example 3). The PCA-based triplot shows that the metabolite profile
predicting BMI was strongly associated with liver enzyme activity, i.e., gamma-glutamyltransferase
(GGT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) (Figure 4), and also with
several other health-related metabolic traits, including fasting glucose, triglycerides, total cholesterol,
as well as high- (HDL) and low-density lipoprotein (LDL) cholesterol (data not shown), in line with
previous studies [24–27]. PC1 reflected metabolites that were positively associated with BMI and
also correlated with a high intake of meat and refined grains and negatively with seafood intake,
in agreement with observational studies [28–30]. We also found that a high intake of fruits correlated
with BMI-related metabolites and other metabolic traits (Figure 4). Fruit consumption is widely
considered an important part of a healthy diet, which may provide a host of beneficial nutrients, i.e.,
vitamins and minerals, dietary fiber, and polyphenols, and aid in the reduction of energy intake and
body weight. However, conflicting results exist regarding associations between fruit intake and risk
factors of NCDs, including BMI [31,32], as supported by the present investigation. Moreover, PC2
contained high negative loadings of, e.g., phosphatidylcholines containing the marine polyunsaturated
fatty acid (C22:6), which in turn correlated positively with seafood intake. From the direct associations
of PC2 with liver enzyme activity we then may speculate that the results support the benefits of seafood
intake, rich in omega-3 polyunsaturated fatty acids, on human health [33–36].
Of note, the triplot can also be easily constructed based on components derived from supervised
modeling of multivariate data (Tutorial—Example 4). To illustrate the wide applicability of the
triplot, we performed PLS modeling on the BMI-related metabolites and assessed associations between
PLS-derived metabolite components with dietary intakes and metabolic traits, which resulted in
similar results as the PCA analysis (Supplementary Materials, Figure S2). The overall direction of
the associations obtained using synthetic data was comparable to the results that were obtained from
authentic data, although the association between PC1 and high intake of meat was not significant in
either synthetic or authentic data (Supplementary Materials, Figure S3).
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Figure 4. A PCA-based triplot visualizing the inter-correlations between plasma metabolites predicting
BMI, dietary intake variables, and metabolic traits, after adjusting for age and gender. Correlations
between PCA components and dietary intakes estimated from food frequency questionnaires
were calculated using the partial Spearman method. Associations of PCA components with
metabolic traits were assessed using linear regression. Only metabolite feature loadings > 0.25,
significant correlations, as well as correlations with animal derived foods and metabolic traits with
strongest associations are shown. ALT: alanine aminotransferase; AST, aspartate aminotransferase;
GGT: gamma-glutamyltransferase.
4. Conclusions
In this work, we have proposed a novel tool, the ‘triplot’, which can be effectively used to visualize
and interpret multivariate risk modeling with high-dimensional data. The framework for integration
of metabolomics data, analyzed using either unsupervised or supervised LV modeling, with dietary
intakes and disease risk or intermediate risk factors was illustrated using two synthetic datasets
representing different study designs. Moreover, our results demonstrate how the triplot could provide
advantages over conventional methods in terms of visualization and interpretation of modeling results
and thus has the potential to assist in extracting biological eaning from complex data.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/9/7/133/s1,
Figure S1: Overall workflow for generation of the data in the original HealthyNordicDiet study. Figure S2:
A PLS-based riplot visualizing the intercorrelations betw en plasma metabolites predicting BMI, di tary intake
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variables, and metabolic traits, adjusting for age and gender in synthetic ‘CAMP’ data. Figure S3: A PCA-based
triplot visualizing the intercorrelations between plasma metabolites predicting BMI, dietary intake variables,
and metabolic traits, adjusting for age and gender in authentic ‘CAMP’ data.
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